With the pace of innovation in the medical device industry occurring at an ever-faster clip, getting products to market quickly is the name of the game. As a result, many OEMs are turning to automated solutions to replace manual assembly processes—especially when it comes to fluid dispensing.

Automated fluid dispensing technology can speed assembly, reduce risks, and enable increased precision—all of which can help medical device manufacturers get better products in their customers’ hands faster.

To help OEMs looking to transition from manual fluid dispensing to an automated system, MD+DI presents Technology Roundup: Boost Throughput and Improve Process Control with Automated Dispensing Solutions, sponsored by ...

November 12th, 2014

Sometimes the highest level of innovation occurs by merely improving an existing device to meet the user’s needs.

By Annie Diorio-Blum

Recently, there has been a trend among medical device companies to focus on innovation and new product development using a “human centered design” approach. Human centered design can have several meanings, but generally it is associated with frequent touch points with the end user at each step in the product development cycle.

However, despite the opportunities for improvement, companies can be understandably hesitant about transforming their entire product development process to include iterative loops with end-users. They already invest a significant amount of time and money developing medical devices to suit the needs...

November 11th, 2014

AdvaMed has had a presence in China for the past few years, but on Monday, it formalized its desire to be in the populous Asian nation.

The medtech industry association and advocacy group based in Washington, D.C., officially opened its China location in Shanghai at a ceremony in Beijing. The move is not surprising given how the medtech industry is looking east to find growth amid a slowdown and challenging healthcare environment in the U.S. and Europe.  

"Today we celebrate the culmination of months of effort to officially open AdvaMed’s representative office in China,” said Stephen Ubl , president and CEO of AdvaMed in a news release. “The new facility in Shanghai – where many of our member companies have their China headquarters – will substantially enhance the association’s ability to...

November 11th, 2014

Medical device manufacturers need to activate their own processes to adequately anticipate and mitigate the safety, security, and business risks that come with connected medical devices.

By Scott Sheaf

Connected medical devices are opening up new possibilities for patients and providers—and introducing new risks to patient safety, data privacy, and IP protection.

At Black Hat 2014, held in Las Vegas in August, the Medical Device Security Roundtable attracted more than 100 attendees eager for answers. But if they came looking for answers, what emerged were more questions that the industry must address—and soon.

Here are five key questions that medical device manufacturers should be asking themselves now.

Are Existing Regulations Enough?

So far, FDA’s...

November 10th, 2014

A new global Laboratory Analytical Workflow standard aims to provide plug-n-play connectivity between IVD tests and health informatics systems.

By Jean Rhame


The IVD Industry Connectivity Consortium (IICC), in partnership with the International Healthcare Enterprise (IHE), has developed a global interoperability standard that is ready for laboratories and IVD manufacturers to adopt. The...

November 7th, 2014

While highly contagious, it is apparently very difficult to contract Ebola unless you are actually taking care of someone who is sick. So all the hyperventilation around quarantining people is a bit misplaced.

If you are looking for the real killers of the human race, look no further than the following infographic - a collbaoration between Good and Column Five - that gives a view of the pandemics that we have encountered through time.

Click on the image for a larger view:


November 7th, 2014

The term compromise seems to have a new ring in the air given the results of the mid-term election.

And while President Barack Obama was clear that he wasn't going to undo the Affordable Care Act, there may be some space now to consider smaller provisions in the law that are problematic.

Already there are rumblings and speculation about what parts of the law may see a demise and what the Republican-led Senate should ask for.

The device tax one, at least on the surface, may be easier to dispense with. The Congressional Research Service has recently described the tax as "challenging to justfy" even though it says its effects are relatively small.  The...

November 6th, 2014

One of the primary rationales of the Medtronic and Covidien mega-merger as propounded by the CEOs of both companies has been the fact that the combined company will be able to sell in more areas of the hospital and extend care to the patient's home.

Breadth and scale have been the dual mantras of the deal with an eye toward being able to bundle different products and sell to the hospital customer.

Recently, Boston Scientific's CEO - Michael Mahoney - called that very premise into question in talking about consolidation in the medtech world. 

Not surprisingly, during Covidien's earnings call on Wednesday, an analyst asked CEO Jose Almeida on how he views the combined...

November 6th, 2014

Oftentimes the highest hurdle separating an idea for a life-saving or -improving medical device from the patients who desperately need it is funding. Though venture capital for medtech overall has finally returned to pre–Great Recession levels, early-stage companies are still having a hard time getting the cash they need to get their innovations off the ground. 

But venture capital isn't the only option for cash-strapped medtech entrepreneurs. As this infographic from product design, development, and strategy firm Worrell shows, bootstrapping, crowdfunding, incubators, and government grants can also be viable sources of funding. 

No matter where your money comes from, there are pros and cons. The...

November 4th, 2014

By Naushad A. Shaik, MD

Determining treatment options for patients suffering from cardiac conditions is rarely a simple process. Physicians are daunted by devices and recommendations that weigh clinical benefits and risk—often one benefit at the expense of another. Single- versus dual-chamber implantable cardioverter devices (ICDs) are a clear illustration of this dilemma.

Is a dual-chamber ICD worth the risk? For patients who have demonstrated pacing indications, dual-chamber ICDs are often selected as the best choice. However, it’s a choice that comes with risk—risk of implantation challenges, lead complication, and mortality. New data also demonstrates no significant increase in survival rates.

Other studies have shown that single-lead...

November 4th, 2014